In 2001, the national institutes of healths diabetes prevention program clearly demonstrated that type 2 diabetes could be delayed or prevented in those at risk for developing diabetes. Over the entire study, the cumulative incidence was 27% lower for the lifestyle group than for the placebo group p summarizes some of the results of the diabetes prevention program outcomes study dppos featured during the american diabetes associations 74 th scientific sessions held at the moscone center june 17, 2014 in san francisco the dppos data is timely, as the centers for disease control and prevention cdc just revealed that 29. Research behind the national dpp centers for disease. Diabetes prevention program outcomes study full text view. Longterm effects of lifestyle intervention or metformin. Dpp participants alive at 1 september 2002 were eligible for the dppos.
The cdc developed the national diabetes prevention program ndpp, a publicprivate partnership working to offer evidencebased, costeffective interventions across the us with the goals of reducing the growing problem of prediabetes and type 2. Dppos is by far the largest of the diabetes prevention studies with a cohort randomly assigned to metformin. Documents provided by national institute of diabetes and digestive and kidney diseases niddk study protocol and statistical analysis plan pdf may 22, 2019. Those who did develop type 2 diabetes delayed the onset of the disease by about 4 years. The diabetes prevention program dpp has been shown to prevent or delay the development of diabetes among individuals with prediabetes. Whether longterm cardiovascular risk is reduced by the diabetes prevention program interventions is unknown. The diabetes prevention program outcomes study dppos is a longterm followup of the dpp to investigate whether the delay in development of diabetes seen during the dpp can be sustained and to assess longterm effects of the interventions on health. Longterm effects of the diabetes prevention program. The longterm followup study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the scientifically and clinically valuable cohort of dpp volunteers and the large volume of data.
Exploring residual risk for diabetes and microvascular. The aim of this study was to determine the longterm differences in cardiovascular disease risk factors and the use of lipid and blood pressure medications by the original diabetes prevention program intervention group. The impact of financial incentives on utilization and. Diabetes prevention program fact sheet the diabetes prevention program dpp was a major clinical trial, or research study, aimed at discovering whether either diet and exercise or the oral diabetes drug metformin could prevent or delay the onset of type 2 diabetes in people with impaired glucose tolerance igt. The diabetes prevention program outcomes study dppos is the longterm followup of the original dpp study. Yet, diabetes prevention studies within the medicaid population are limited and results are mixed. The diabetes prevention program dpp was a major clinical trial, or research study, aimed at discovering whether either diet and exercise or the oral diabetes drug metformin could prevent or delay the onset of type 2 diabetes in people with impaired glucose tolerance igt.
The dppdiabetes prevention program outcomes study dppos. The diabetes prevention program dpp was a multicenter trial examining the ability of an intensive lifestyle or metformin to prevent or delay the development of diabetes in a high risk population due to the presence of impaired glucose tolerance igt, 2 hour glucose of 140199 mgdl. The diabetes prevention program dpp, funded by the national institute of diabetes and digestive and kidney diseases niddk and conducted at 25 centers nationwide, was a landmark trial to show that lifestyle changes or metformin can effectively delay diabetes in a diverse population of overweight or obese american adults at high risk of diabetes in the short term. The national diabetes prevention program national dpp is rapidly expanding in an effort to help those at high risk of type 2 diabetes prevent or delay the disease. Some evidence suggests interventions adapted from the u. Diabetes prevalence has risen rapidly and has become a global health challenge. The goal of dppos was to study whether the relatively shortterm benefits of. Diabetes prevention program study and diabetes prevention. Diabetes prevention program outcomes study study results. Diabetes prevention program outcomes study study documents go back to all study documents index of forms. The largest and longest clinical trial of metformin for the prevention of diabetes is the diabetes prevention program diabetes prevention program outcomes study dppdppos. The followup study, the diabetes prevention program outcomes study dppos, was initiated in 2002 to measure the longterm effects of interventions used in the dpp study on the development of type 2 diabetes and associated complications. A 10year followup study, the diabetes prevention program outcomes study external, showed that participants were still onethird less likely to develop type 2 diabetes a decade later than individuals who took a placebo. The diabetes prevention program dpp and dpp outcomes study dppos periods, and the overlap between them, are shown.
Notice of change to cover letter instructions for rfadk20502, limited competition for the continuation of the diabetes prevention program outcomes study dppos biostatistics research center brc collaborative u01 clinical trial required notdk20017. The niddksponsored diabetes prevention program dpp and ongoing dpp outcomes study dppos are major studies that changed the way people approach type 2 diabetes prevention worldwide. Longterm safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study. The dppos study sought to evaluate the effects of the interventions on the further development of diabetes and diabetes complications, including retinopathy, microangiopathy, and cardiovascular disease. Diabetes prevention program outcomes study dppos niddk. Diabetes prevention program fact sheet national kidney.
The dpp enrolled participants over a 3year period ending june 1999, therefore participants had varying duration of dpp followup depending on their year of enrolment. The diabetes prevention program dpp, funded by the national institute of. The dpp showed that people who are at high risk for type 2 diabetes can prevent or delay the disease by losing a modest amount of weight through lifestyle changes dietary changes and increased physical activity. The diabetes prevention program dpp was a major clinical trial. After 10 years followup from diabetes prevention program baseline, major reductions were seen for systolic 23 mmhg and diastolic 56 mmhg blood pressure, and for ldl cholesterol 0. Diabetes prevention program outcomes study full text. Prospective intervention studies with treatment of long duration and. In fact, the dpp found that over the three years of the study, diet and exercise.
Diabetes prevention program diabetes prevention program research group 2002, niddk 2016 reduce rates of. Diabetes prevention program dpp study was initiated in 1996 as a randomized controlled clinical. Nih funding opportunities and notices in the nih guide for grants and contracts. The diabetes prevention program dpp was a major multicenter clinical research study aimed at discovering whether modest weight loss through dietary changes and increased physical activity or treatment with the oral diabetes drug metformin glucophage could prevent or delay the onset of type 2 diabetes in study participants. Persons are considered at high risk for diabetes if they. The diabetes prevention program outcomes study dppos, the 10year followup study to. Diabetes prevention program outcomes study dppos, was initiated in 2002 to measure the. To allow nih to identify a group of applications as a related set of collaborative applications, the titles for each application in the set must have the following format. Niddk central repository diabetes prevention program outcomes study dppos resource description, availability, and access.
1091 1349 863 1028 715 936 982 1490 470 337 392 1412 1586 1184 1136 804 743 241 1452 119 1604 1156 1446 738 133 716 1505 1349 189 655 925 558 1000 830 883 98 870 1101 525